Related Experiment Video
Updated: May 8, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Molecular Pathology of Myeloid Neoplasms
Hannah Goulart1, Sanam Loghavi2
1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
None:
This article summarizes the contemporary diagnostic and prognostic frameworks for myeloid neoplasms, with a focus on myelodysplastic neoplasms/syndromes and acute myeloid leukemia. The authors focus on the updated classification systems per the fifth edition of the World Health Organization Classification and International Consensus Classification and specifically emphasize the increasing role of cytomolecular profiling in disease classification and risk-stratification models. The authors expand on testing methodologies, practical guidelines for implementation, and therapeutic implications of key molecular alterations to provide actionable insights for clinicians and pathologists.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

